Hello Share Chirpers. Once again, hostilities threaten the world. The Americans have launched a missile strike on a Syrian airfield. The Russians and the Iranians don’t like it. The Middle East is in even more turmoil.

AIM-listed Advanced Oncotherapy (AVO) has announced a second conversion of death-spiral loan by Bracknor. As per the first conversion, it is £100,000 (nominal) but this time the conversion price was just 27.89p. Given that the recent EGM gave approval for the company to convert the full package at an average 44p per share that might mean a bit of a headache.

In this video from the storming success that was the 2017 UK Investor Show, Dave Mutton, Chief Operating Officer of PrimaryBid, is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.

Having asked for readers tips for 2017 for the amazing prize of a meal with Tom Winnifrith (or the chance to fob it off on someone you don't like) HERE, the following is a monthly update on performance (to be eligible needed to have selected, on a per username basis, a buy & sell pick from the LSE or AIM Casino and the stocks not to have been suspended at the commencement of 2017)...

In this video from the storming success that was the 2017 UK Investor Show, Keith Allaun of Powerhouse Energy (PHE) is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.

Previously updating on hobby products group, Hornby (HRN) I concluded that some decent underlying progress looking to now be being made saw the shares onto the watchlist for recovery. The company has now further updated…

It is a sign of the times that three of the ten pages in this broker note are covering regulatory disclosures. Stifel acts as broker to Amryt (AMYT) so feel free to disregard all that it says. None the less, since FIML owns a shed load of these shares, a prediction that the stock should treble is surely worth reporting.

Just catching up with an after-hours RNS from Xtract Resources (XTR) on Wednesday and although I was hoping for an update on how it is going to finance Manica, it was in fact just more dilution taking the total number of shares to over 34 billion…..with more to come...

I most recently cautioned on water technology company HaloSource (HALO) in February HERE. It has now announced results for the 2016 calendar year…

In this video from the storming success that was the 2017 UK Investor Show, Paul Roberts of Stockomendation is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.

URU Metals (URU) seems to have this RNS lark cracked – if the market hates the first one that you issue, then just word it slightly differently and release news about the same project again the following day. You really couldn’t make it up!

In this video from the storming success that was the 2017 UK Investor Show, Video: Christian Hipkiss, CEO of Harley Investments speaks at UK Investor Show 2017 is at the podium.  Since this is property related, Britain's Buffett, Nigel Wray gave the introduction. Make sure that you keep April 21 2018 free for next year's UK Investor Show.

Hello Share Swiggers. Those of you lucky enough to attend the big UK Investor Show last weekend will have been treated to the first-time ever stage appearance of the Pizza Hardman, Darren Atwater. What was remarkable about this event is that the share he picked in his 'Dragon’s Den' session has put on 20% in the first few days.

OptiBiotix (OPTI) skin health-focused subsidiary, SkinBioTherapeutics, has successfully listed its shares on AIM. Good news as OptiBiotix still has a near 42% stake…

Following the botched Director Dealings RNS of Tuesday, this afternoon AIM-listed Advanced Oncotherapy has ‘fessed up to another foul-up. This time it refers to an RNS released way back on November 7^th last year when the company announced that it had issued 266,668 new shares from the exercise of options at 87.5p per share. Except that it hadn’t.

In this video from the storming success that was the 2017 UK Investor Show, Satu Vainikka of Valirx (VAL) is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.

One of the advantages of taking a trip to an event such as the sell-out soaraway success that was this year’s UK Investor Show is the opportunity to meet and speak directly to the very people running the companies in which you might invest or already be invested. I took my opportunity to chat with AIM-listed Minoan (MIN) – a share I’ve held for so long I can’t remember when I first bought it.

Is this the Tax Year in which you are going to sort your pension out? If we are correct and both Equity and Bond markets are in bubbles, which are set to burst, then a large amount of the wealth build up in a pension(s) could evaporate without the right Investment Strategy.

Previously commenting on blur Group (BLUR) I noted CEO Letts & co excelling themselves with a leading contender for ‘Ramparoonie RNS of the Year’. We today have a “blur engaged with UK County Council” announcement. Surely not again…

In this video from the storming success that was the 2017 UK Investor Show, Joost Boer of Bigdish Ventures is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.